Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrin Sealant vs Ligature for Bleeding Esophageal Varices
NCT00161915Phase 3Completed
- Sponsor
- Baxter
- Start
- Dec 2000
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tisseel in Esophageal variceal hemorrhage (EVH) (2 arms), sponsored by Baxter. Primary endpoint: Therapeutic success defined as survival of the first seven days without clinically significant bleeding at 7 days. Started Dec 2000; status: completed.
02
Drugs
tisseel
03
Conditions
Esophageal variceal hemorrhage (EVH)
Beyond the preview
Go deeper on NCT00161915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161915.